Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-05 Biller Scott Chief Scientific Officer Sale −701 $76.76 $54K 53,459
2018-02-05 Biller Scott Chief Scientific Officer Sale −400 $78.03 $31K 53,059
2018-02-05 Biller Scott Chief Scientific Officer Option exercise · Stock options (right to buy) −64 1,803
2018-02-05 Biller Scott Chief Scientific Officer Option exercise · Stock options (right to buy) −2,936 31,154
2018-02-01 Bowden Christopher Chief Medical Officer Option exercise +2,000 $35.16 $70K 2,881
2018-02-01 Bowden Christopher Chief Medical Officer Sale −1,315 $78.50 $103K 1,566
2018-02-01 Bowden Christopher Chief Medical Officer Sale −685 $79.23 $54K 881
2018-02-01 Bowden Christopher Chief Medical Officer Option exercise · Stock option (right to buy) −2,000 107,000
2018-02-01 Schenkein David P Chief Executive Officer Option exercise +13,000 $0.30 $4K 13,000
2018-02-01 Schenkein David P Chief Executive Officer Sale −8,540 $78.50 $670K 4,460
2018-02-01 Schenkein David P Chief Executive Officer Sale −4,460 $79.23 $353K 0
2018-02-01 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −13,000 104,567
2018-01-26 Schenkein David P Chief Executive Officer Option exercise +23,572 $0.30 $7K 23,572
2018-01-26 Schenkein David P Chief Executive Officer Sale −9,237 $80.35 $742K 14,335
2018-01-26 Schenkein David P Chief Executive Officer Sale −11,369 $81.40 $925K 2,966
2018-01-26 Schenkein David P Chief Executive Officer Sale −2,966 $82.22 $244K 0
2018-01-26 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −23,572 117,567
2018-01-24 Schenkein David P Chief Executive Officer Option exercise +20 $0.30 $6 20
2018-01-24 Schenkein David P Chief Executive Officer Sale −20 $80.01 $2K 0
2018-01-24 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −20 141,139

Page 67 of 80 · 1,590 trades